Metal-organic frameworks as potential drug delivery systems

Bibliography

• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145‐60
   PubMed Web of Science ®Google Scholar
• Yoo JW, Lee CH. Drug delivery systems for hormone therapy. J Control Release 2006;112:1‐14
   PubMed Web of Science ®Google Scholar
• Gupta M, Agrawal U, Vyas SP. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Exper Opin Drug Deliv 2012;9:783‐804
   PubMed Web of Science ®Google Scholar
• Vallet-Regί M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007;46:7548‐58
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771‐82
   PubMed Web of Science ®Google Scholar
• Dyson PJ, Sava G. Metal-based antitumour drugs in the post genomic era. Dalton Trans 2006;16:1929‐33
   PubMed Web of Science ®Google Scholar
• Fathabadi EG, Shelling AN, Al-Kassas R. Nanocarrier systems for delivery of siRNA to ovarian cancer tissues. Exper Opin Drug Deliv 2012;9:743‐54
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Biodegradable polymeric nanoparticles as drug delivery systems. J Control Release 2001;70:1‐20
   PubMed Web of Science ®Google Scholar
• Dhivanand P, Sprockel OL. A controlled porosity drug delivery system. Int J Pharm 1998;167:83‐96
   Web of Science ®Google Scholar
• Vallet-Regi M, Ramila A, del Real RP, Perez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mater 2001;13:308‐11
   Web of Science ®Google Scholar
• Wang XL, Qin C, Wu SX, Bottom-up synthesis of porous coordination frameworks: apical substitution of a pentanuclear tetrahedral precursor. Angew Chem Int Ed 2009;48:5291‐5
   PubMed Web of Science ®Google Scholar
• Seo JS, Whang D, Lee H, A homochiral metal-organic porous material for enantioselective separation and catalysis. Nature 2000;404:982‐6
   PubMed Web of Science ®Google Scholar
• Serra-Crespo P, van der Veen MA, Gobechiya E, NH2-MIL-53(Al): a high-contrast reversible solid-state nonlinear optical switch. J Am Chem Soc 2012;134:8314‐17
   PubMed Web of Science ®Google Scholar
• Allendorf MD, Bauer CA. Bhakta, RK, et al. Luminescent metal–organic frameworks. Chem Soc Rev 2009;38:1330‐52
   PubMed Web of Science ®Google Scholar
• Eddaoudi M, Kim J, Rosi N, Systematic design of pore size and functionality in isoreticular MOFs and their application in methane storage. Science 2002;295:469‐72
   PubMed Web of Science ®Google Scholar
• Yuan D, Zhao D, Sun D, An isoreticular series of metal-organic frameworks with dendritic hexacarboxylate ligands and exceptionally high gas-uptake capacity. Angew Chem Int Ed 2010;49:5357‐61
   PubMed Web of Science ®Google Scholar
• Qin JS, Du DY, Li WL, N-rich zeolite-like metal–organic framework with sodalite topology: high CO2 uptake, selective gas adsorption and efficient drug delivery. Chem Sci 2012;3:2114‐18
   Web of Science ®Google Scholar
• Lee CY, Bae YS, Jeong NC, Kinetic separation of propene and propane in metal−organic frameworks: controlling diffusion rates in plate-shaped crystals via tuning of pore apertures and crystallite aspect ratios. J Am Chem Soc 2011;133:5228‐31
   PubMed Web of Science ®Google Scholar
• Kitaura R, Fujimoto K, Noro S, A pillared-layer coordination polymer network displaying hysteretic sorption: [Cu2(pzdc)2(dpyg)]n (pzdc = pyrazine-2,3-dicarboxylate; dpyg = 1,2-Di(4-pyridyl)glycol). Angew Chem Int Ed 2002;41:133‐5
   PubMed Web of Science ®Google Scholar
• Lan YQ, Jiang HL, Li SL. Mesoporous metal-organic frameworks with size-tunable cages: selective CO2 uptake, encapsulation of Ln3+ cations for luminescence, and column-chromatographic dye separation. Adv Mater 2011;23:5015‐20
   PubMed Web of Science ®Google Scholar
• Imaz I, Rubio-Martínez M, An J, Metal–biomolecule frameworks (MBioFs). Chem Commun 2011;47:7287‐302
   PubMed Web of Science ®Google Scholar
• Furukawa H, Ko N, Go YB, Ultrahigh porosity in metal-organic frameworks. Science 2010;329:424‐8
   PubMed Web of Science ®Google Scholar
• Morris RE, Wheatley PS. Gas storage in nanoporous materials. Angew Chem Int Ed 2008;47:4966‐81
   PubMed Web of Science ®Google Scholar
• Horcajada P, Chalati T, Serre C, Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat Mater 2010;9:172‐6
   PubMed Web of Science ®Google Scholar
• Bertini I. Biological inorganic chemistry: structure and reactivity. University Science Books; Sausalito, CA: 2007
   Google Scholar
• Horcajada P, Gref R, Baati T, Metal–organic frameworks in biomedicine. Chem Rev 2012;112:1232‐68
   PubMed Web of Science ®Google Scholar
• Mizutani M, Maejima N, Jitsukawa K, An infinite chiral single-helical structure formed in Cu(II)-L-/D-glutamic acid system. Inorg Chim Acta 1998;283:105‐10
   Web of Science ®Google Scholar
• An J, Geib SJ, Rosi NL, Cation-triggered drug release from a porous zinc-adeninate metal-organic framework. J Am Chem Soc 2009;131:8376‐7
   PubMed Web of Science ®Google Scholar
• Smaldone RA, Forgan RS, Furukawa H, Metalorganic frameworks from edible natural products. Angew Chem Int Ed 2010;49:8630‐4
   PubMed Web of Science ®Google Scholar
• McKinlay AC, Morris RE, Horcajada P, BioMOFs: metal–organic frameworks for biological and medical applications. Angew Chem Int Ed 2010;49:6260‐6
   PubMed Web of Science ®Google Scholar
• Horcajada P, Serre C, Vallet-Regί M, Metal–organic frameworks as efficient materials for drug delivery. Angew Chem Int Ed 2006;45:5974‐8
   PubMed Web of Science ®Google Scholar
• Horcajada P, Serre C, Maurin G, Flexible porous metal-organic frameworks for a controlled drug delivery. J Am Chem Soc 2008;130:6774‐80
   PubMed Web of Science ®Google Scholar
• Sun CY, Qin C, Wang XL, Zeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle. Dalton Trans 2012;41:6906‐9
   PubMed Web of Science ®Google Scholar
• Doane TL, Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery. Chem Soc Rev 2012;41:2885‐911
   PubMed Web of Science ®Google Scholar
• Chalati T, Horcajada P, Gref R, Optimisation of the synthesis of MOF nanoparticles made of flexible porous iron fumarate MIL-88A. J Mater Chem 2011;21:2220‐7
   Web of Science ®Google Scholar
• Hermes S, Witte T, Hikov T, Trapping metal-organic framework nanocrystals: an in-situ time-resolved light scattering study on the crystal growth of MOF-5 in solution. J Am Chem Soc 2007;129:5324‐5
   PubMed Web of Science ®Google Scholar
• Horcajada P, Serre C, Grosso D, Colloidal route for preparing optical thin films of nanoporous metal-organic frameworks. Adv Mater 2009;21:1931‐5
   Web of Science ®Google Scholar
• Cravillon J, Munzer S, Lohmeier SJ, Rapid room-temperature synthesis and characterization of nanocrystals of a prototypical zeolitic imidazolate framework. Chem. Mater 2009;21:1410‐12
   Web of Science ®Google Scholar
• Cho W, Lee HJ, Oh MJ. Growth-controlled formation of porous coordination polymer particles. J Am Chem Soc 2008;130:16943‐6
   PubMed Web of Science ®Google Scholar
• Rieter WJ, Taylor KML, An H, Nanoscale metal organic frameworks as potential multimodal contrast enhancing agents. J Am Chem Soc 2006;128:9024‐5
   PubMed Web of Science ®Google Scholar
• Qiu LG, Li ZQ, Wu Y, Facile synthesis of nanocrystals of a microporous metal–organic framework by an ultrasonic method and selective sensing of organoamines. Chem. Commun 2008;3642‐4
   PubMed Web of Science ®Google Scholar
• Jhung SH, Lee JH, Yoon JW, Microwave synthesis of chromium terephthalate MIL-101 and its benzene sorption ability. Adv Mater 2007;19:121‐4
   Web of Science ®Google Scholar
• Taylor KML, Rieter WJ, Lin W. Manganese-based nanoscale metal–organic frameworks for magnetic resonance imaging. J Am Chem Soc 2008;130:14358‐9
   PubMed Web of Science ®Google Scholar
• Taylor-Pashow KML, Rocca JDe, Xie Z, Postsynthetic modifications of iron-carboxylate nanoscale metal–organic frameworks for imaging and drug delivery. J Am Chem Soc 2009;131:14261‐3
   PubMed Web of Science ®Google Scholar
• Gref R, Domb A, Quellec P, The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 1995;16:215‐33
   PubMed Web of Science ®Google Scholar
• Horcajada P, Márquez-Alvarez C, Rámila A, Controlled release of Ibuprofen from dealuminated faujasites. Solid State Sci 2006;8:1459‐65
   Web of Science ®Google Scholar
• Walko CM, Lindley C. Capecitabine: a review. Clin Ther 2005;27:23‐44
   PubMed Web of Science ®Google Scholar
• Scalvini A, Ferrari V, Bodei S, Involvement of target gene polymorphisms in 5-fluorouracil toxicity: a Case Report. Pharmacology 2012;89:99‐102
   PubMed Web of Science ®Google Scholar
• Yi H, Cho HJ, Cho SM, Research article pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel. BMC Cancer 2010;10:211‐18
   PubMed Web of Science ®Google Scholar
• Wang HN, Meng X, Yang GS, Stepwise assembly of metal–organic framework based on a metal–organic polyhedron precursor for drug delivery. Chem Commun 2011;47:7128‐30
   PubMed Web of Science ®Google Scholar
• Li XL, Li H, Liu GQ, Magnetite-loaded fluorine-containing polymeric micelles for magnetic resonance imaging and drug delivery. Biomaterials 2012;33:3013‐24
   PubMed Web of Science ®Google Scholar
• Wang HN, Meng X, Wang XL, Auxiliary ligand induced structural allomorphism in nanotubular microporous metal–organic frameworks based on discrete magnesium clusters. Dalton Trans 2012;41:2231‐3
   PubMed Web of Science ®Google Scholar
• Sun CY, Qin C, Wang CG. Chiral Nanoporous metal-organic frameworks with high porosity as materials for drug delivery. Adv Mater 2011;23:5629‐32
   PubMed Web of Science ®Google Scholar
• Jung J, Lee IH, Lee E, pH-sensitive polymer nanospheres for use as a potential drug delivery vehicle. Biomacromolecules 2007;8:3401‐7
   PubMed Web of Science ®Google Scholar
• Park KS, Ni Z, Côté AP, Exceptional chemical and thermal stability of zeolitic imidazolate frameworks. Proc Natl Acad Sci USA 2006;103:10186‐91
   PubMed Web of Science ®Google Scholar
• Banerjee R, Phan A, Wang B, High-throughput synthesis of zeolitic imidazolate frameworks and application to CO2 capture. Science 2008;319:939‐43
   PubMed Web of Science ®Google Scholar
• Shi Q, Chen ZF, Song ZW, Synthesis of ZIF-8 and ZIF-67 by steam-assisted conversion and an investigation of their tribological behaviors. Angew Chem Int Ed 2011;50:672‐5
   PubMed Web of Science ®Google Scholar
• An J, Geib SJ, Rosi NL. Cation-triggered drug release from a porous zinc adeninate metal–organic framework. J Am Chem Soc 2009;131:8376‐7
   PubMed Web of Science ®Google Scholar
• Rocca JD, Liu D, Lin W. Nanoscale metal–organic frameworks for biomedical imaging and drug delivery. Acc Chem Res 2011;44:957‐68
   PubMed Web of Science ®Google Scholar
• Taylor-Pashow KML, Rocca JD, Xie Z, Postsynthetic modifications of iron-carboxylate nanoscale metal–organic frameworks for imaging and drug delivery. J Am Chem Soc 2009;131:14261‐3
   PubMed Web of Science ®Google Scholar
• Loehrer PJ, Einhorn LH. Drugs five years later. Cisplatin. Ann Intern Med 1984;100:704‐13
   PubMed Web of Science ®Google Scholar
• Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncol Rep 2003;10:1663‐82
   PubMed Web of Science ®Google Scholar
• Pinzani V, Bressolle F, Johannehaug I, Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemoth Pharm 1994;35:1‐9
   PubMed Web of Science ®Google Scholar
• Hartmann JT, Kollmannsberger C, Kanz L, Platinum organtoxicity and possible prevention in patients with testicular cancer. Int J Cancer 1999;83:866‐9
   PubMed Web of Science ®Google Scholar
• Bosch ME, Sanchez AJ, Rojas FS, Analytical methodologies for the determination of cisplatin. J Pharmceut Biomed 2008;47:451‐9
   PubMed Web of Science ®Google Scholar
• Giaccone G. Clinical perspectives on platinum resistance. Drugs 2000;59:9‐17
   PubMed Web of Science ®Google Scholar
• Miller SR, Heurtaux D, Baati T, Biodegradable therapeutic MOFs for the delivery of bioactive molecules. Chem Commun 2010;46:4526‐8
   PubMed Web of Science ®Google Scholar
• Ahmad S, Isab AA, Ali S, Perspectives in bioinorganic chemistry of some metal based therapeutic agents. Polyhedron 2006;25:1633‐45
   Web of Science ®Google Scholar
• de Paiva REF, Abbehausen C, Gomes AF, Synthesis, spectroscopic characterization, DFT studies and antibacterial assays of a novel silver(I) complex with the anti-inflammatory nimesulide. Polyhedron 2012;36:112‐19
   Web of Science ®Google Scholar
• Xiao B, Wheatley PS, Zhao X, High-capacity hydrogen and nitric oxide adsorption and storage in a metal–organic framework. J Am Chem Soc 2007;129:1203‐9
   PubMed Web of Science ®Google Scholar
• McKinlay AC, Xiao B, Wragg DS, Exceptional behavior over the whole adsorption–storage–delivery cycle for NO in porous metal organic frameworks. J Am Chem Soc 2008;130:10440‐4
   PubMed Web of Science ®Google Scholar